Follow The Filings

LMRI Lumexa Imaging

Lumexa Imaging earnings company data as of 4:48 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS 0.07 — —
Rev — — —

Insider trades

Open-market buys and sales by LMRI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LMRI insider trades
  • $477K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Brett Brodnax Director
    Buy
    $254K 35,000 shares at $7.25 +130% to stake
    Traded May 19 Filed May 21
  2. Henry Lee Cooper Director
    Buy
    $223K 30,000 shares at $7.44 New stake
    Traded May 14 Filed May 18

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
SCHEDULE 13G —
10-Q
8-K 2.02,7.01,9.01
8-K 1.01,2.03,9.01
8-K 5.07,9.01
8-K 2.02,7.01,9.01
10-Q
DEF 14A
DEFA14A
8-K 7.01
10-K
8-K 2.02,7.01,9.01
8-K 2.02,7.01,9.01
SCHEDULE 13G —
8-K 5.02,9.01
8-K 1.01,2.03,9.01
424B4
8-K 1.01,5.02,5.03,8.01,9.01
S-1/A
S-1

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.